{"name":"NImmune Biopharma","slug":"nimmune-biopharma","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxQRXhLWXVaNHhKRUYzeWZQSko1SGtUdnR6WjV0QWMwcWw1c2VqZWpFd3BfODh5UEJ4V0JCRzZvbU9yMXdVZGNZVU9rdEUzeG9tWGhwbHFfWENDR0YtSFpvNGNaWkpwMVdTWjhwTWppaVVNMUJWY0JSRWZxTFdqM2pLVngzQjZncUI2dUY0ZEZWcC15TWRmMWY4NXFvaFFMT3l3X3c?oc=5","date":"2026-03-27","type":"regulatory","source":"BioPharma Dive","summary":"Rocket gene therapy cleared by FDA for rare immune disorder - BioPharma Dive","headline":"Rocket gene therapy cleared by FDA for rare immune disorder","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxPc0tweGZhMldZNS1XdldDMmRqTHFLX0lyUEVBWEwxTWdJMHhtcFV1Y3RqUVl3dmtiRnJWS08wSTZZX1N3Tm1mUVZBQU95MGNRVTFGa1N2LWViT1RKanB5X2ttanFreWFmb1pqR2FOUjRMY29ldkpKbUJUOWNHdXBJNmtqVlFKZjBKaXFnMGlrc2FJaHVEelhYc0c1UUtLV1UtcmlQcA?oc=5","date":"2026-03-11","type":"pipeline","source":"24/7 Wall St.","summary":"Josh Brown: Biotech growth stocks immune to disruption risk - 24/7 Wall St.","headline":"Josh Brown: Biotech growth stocks immune to disruption risk - 24/7 Wall St.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxPN19hRGVGVW5NdUpWcWlkWElUZXZLM2ZDTkgzeVBObzltZGdFYWI4RzBqNWthOFBiQXdyREF1WlJFQ0IyUW42RVZhMmxHR1ltZU5CbUlnUUZkcklvQ3BmMnNmS09pQ0Q1QnV3eERaU0I0WlktWHJDcXBvd3p1bDJNajB0d1EtMFFFb25jbjNuVUJta1JidVZ2VFpWU1FRWGd4QWVR?oc=5","date":"2026-02-18","type":"patent","source":"Contract Pharma","summary":"Pluri Biotech Secures China Patent for Immune Cell Tech - Contract Pharma","headline":"Pluri Biotech Secures China Patent for Immune Cell Tech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE9wdFBQYWNxTzZmYmFwUXRSWm1UTkxKZmd3TGNXTERKTWo0S2lESWpmMFJ3bjdudEo4QVB5dFlucF9nT1FGYXJmTHNQd0w0UUFXaUtF?oc=5","date":"2026-02-18","type":"deal","source":"FirstWord Pharma","summary":"Biopharma bites: Bhattacharya takes up temporary CDC helm, Sensei buys Faeth, and more from J&J and AC Immune - FirstWord Pharma","headline":"Biopharma bites: Bhattacharya takes up temporary CDC helm, Sensei buys Faeth, and more from J&J and AC Immune","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxQcHA1V0dJMTMybjBMRW1xOXlBNlJqdzMwQVY4RWdDZG5kR25fYXoxcHJwVmhCQ3BlVTE1TmM5WkdyV3luaGh4NFZxZ2NyWjI2dl8wNmwyclZwRWM0eGFYY1J4cFVKYkRneVB3T3V5MXlOSmRyekJnZjhBcEt6bndMYkxhYVpacVJnQzg2Qkx4THA4OUF6QWc4SlFFcWRBbE94SmlHUDJ1TkRrVzlFbDhYLTFiMmwzZElaUnRwS0pB?oc=5","date":"2026-01-29","type":"deal","source":"Fierce Biotech","summary":"Repertoire adds Lilly to range of Big Pharma partners in autoimmune deal worth up to $1.9B - Fierce Biotech","headline":"Repertoire adds Lilly to range of Big Pharma partners in autoimmune deal worth up to $1.9B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxPSkJHVkp1OENhMjVlNnlXelNQN2R5S3EzRFZTbmJRd3pLTWxNRnUxVGgwN2toa2Fuc2xXS181WFlZX21SeGxORWJCc0NONDJBbm43b2cyN0pHTURBT1hNUkowby13MWpMNkV0MHBnbERWNDNVclNlNjdzQ2FPbHRnSnFJQkxzSW13a3d0REtB?oc=5","date":"2026-01-05","type":"trial","source":"BioPharma Dive","summary":"Zenas shares crash after top drug misses expectations in immune disease study - BioPharma Dive","headline":"Zenas shares crash after top drug misses expectations in immune disease study","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaDBBMzUtT1lhdHFlckc5Z0hIYV85OFlUSDZKel93Uy1XWi1NZVBLQU1EU0ZFTEhnZVBha3NEWV9CN1IwbnMzNzlqTnB2UGVMbmw5WU0tME43MjdFakF5MVRvWmt4R0ZWekg3NDgtWXFwVXk4OXkwcXQwZG1yTnQyWEdDUENJUkZXMUNtQWQxNmxWN0lHWFhNV0tyUW1PcjJaVXFBQzJRWVc?oc=5","date":"2025-12-10","type":"pipeline","source":"BioPharma Dive","summary":"A Roivant spinout bets on AI-designed drugs for immune conditions - BioPharma Dive","headline":"A Roivant spinout bets on AI-designed drugs for immune conditions","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxQU1dqcmZ2ZkFWMGU2WVlXUmtKVUNHbUVDa05VYmJOaE51TW42MlJQS05uaHRMWHZ3MTU0Q1lMUklfY2pfemYzUGUzVWhCNGhkd08yc2FLMFNNUElxTWlkSlhZSVV3NG9EMll1VnBtTFRVLWFVTGxPT2tpckR4U0dJLS1WSXMxX05fbkg3ckIxOFBpR01VbGd0bFAySExQRVA5VlZiMnNlQUNzNmN5Um1RSFhVQ25Xam5N?oc=5","date":"2025-11-24","type":"deal","source":"BioPharma Dive","summary":"Biogen strikes deal with Versant-backed biotech to expand immune portfolio - BioPharma Dive","headline":"Biogen strikes deal with Versant-backed biotech to expand immune portfolio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNaEhqZnU3N1RwV2VEMkFfTzNaSWFzdlF6R094SHBIM0VHQmtKUUhDRXBVT1hoczhtSnd4Zk5HbUtxOVAyT3Q0bUhHaHVPRVctUjVpMXQ5eUtrQ0JTVjBTVkwwSHI0ZkJ6RGNTWGp1V2ZHcUctUFN1OWk3X2pVeDVXbUZ5ZUZmYU1lS3poWnVwMUhudlh6Q1FzUXQzeXM?oc=5","date":"2025-10-24","type":"deal","source":"BioPharma Dive","summary":"Biogen licenses a possible immune drug from OrbiMed-backed biotech - BioPharma Dive","headline":"Biogen licenses a possible immune drug from OrbiMed-backed biotech","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-09-29","type":"pipeline","source":"Diario AS","summary":"China dodges pharmaceutical tariffs: “Most Chinese biotech companies are immune to tariffs” - Diario AS","headline":"China dodges pharmaceutical tariffs: “Most Chinese biotech companies are immune to tariffs”","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxQaFVJRVZsVXVvQzBZYWpKVUk5clFWcjliUFd5WmtBLVB6TDUzMlQ1V3ZTbWZkNzdqekM4eUJ5bjM1RXl3bGJ6ZzJ1NGlrMzJlVzJ2N3BCLU45TTVhNVdnVzZQS2dldWtrSGwxVzRDNVpVQkR4dHRMaGFIVnZfbm5pMnFuVWRVRm1NeFhNTUM2UEJJUzZ3eS15dW52UEtiT1NoZTV0RXd5TkJfbzZhbXVz?oc=5","date":"2025-09-02","type":"regulatory","source":"Contract Pharma","summary":"Sanofi’s Wayrilz Approved by FDA to Treat Immune Thrombocytopenia - Contract Pharma","headline":"Sanofi’s Wayrilz Approved by FDA to Treat Immune Thrombocytopenia","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxPU1NEY3F5SGNTOWtyOFpYRkZhZVBfV1FNRVVTam1BcE9UWWNQUVU3aFZ5SmxGQW9ybjY4blhmUkFHYWhDUVNnTGMyWlowemNWaV93alhLN0QzeUNvWGl6MHNfaVRYVHQ3WVN4SmxIb0twM2dMZmFRaDBWQ3pmdVdIMTZzenZKVVlBZEtGOWVfeExaOEotS2FTVVJ4eS1MYk1tSXpvcFFmNFJ6RVZRNnc?oc=5","date":"2025-08-26","type":"deal","source":"Fierce Biotech","summary":"Sitala, backed by Forbion and OrbiMed, seals $670M deal for Fosun immune disease drug - Fierce Biotech","headline":"Sitala, backed by Forbion and OrbiMed, seals $670M deal for Fosun immune disease drug","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}